http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 27 Jul 2026 20:00:15 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html <p>Devonian Health Group Inc. (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company based in Quebec, Canada, announced plans to conduct an underwritten public offering of common shares and warrants, concurrent with a proposed listing on the NYSE American LLC.</p> <p>The company expects its common shares and warrants to trade on the NYSE American under the symbols "DHGR" and "DHGRW," respectively, subject to final authorization of its listing application and continued compliance with exchange rules. No offering size or terms were disclosed in the announcement.</p> <p>ThinkEquity is serving as the sole book-running manager for the offering. A registration statement has been filed with http://www.streetinsider.com/Equity+Offerings/Devonian+Health+Group+plans+NYSE+American+listing+and+share+offering/26820797.html Mon, 27 Jul 2026 20:00:15 -0400 A.19657706 DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/Press+Releases/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LS/ca.qc" idsrc="xmltag.org" >QUÉBEC</location></span>, <span class="legendSpanClass"><chron>July 27, 2026</chron></span> /PRNewswire/ -- <b><span value="TorontoVE:GSD" idsrc="xmltag.org" >Devonian Health Group Inc.</span></b> ("<b>Devonian</b>" or the "<b>Company</b>") (TSXV: GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten public offering of its common shares (and/or pre-funded warrants in lieu thereof) and warrants (the "Warrants") (the "Offering"). Concurrently with the Offering, the Company expects its common shares and Warrants to be approved for listing on the <span>NYSE American LLC</span> (the "NYSE American") under the symbols "DHGR" and "DHGRW", respectively, subject to final authorization of http://www.streetinsider.com/PRNewswire/Devonian+Health+Group+Announces+Proposed+Listing+on+the+NYSE+American+with+Concurrent+Underwritten+Public+Offering/26820796.html Mon, 27 Jul 2026 20:00:00 -0400 A.19657706 DHGR DHGR DHGRW DVHGF GSD O.36250936 O.47005133 http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Devonian+Health+Group++++++++++++++++/26820593.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260727/A7BZQ22C8Z2242ZZ27ZS2CZZGWEKZ2U2ZL8G">http://archive.fast-edgar.com/20260727/A7BZQ22C8Z2242ZZ27ZS2CZZGWEKZ2U2ZL8G</a></p> <p> Filed on: July 27, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Devonian+Health+Group++++++++++++++++/26820593.html Mon, 27 Jul 2026 17:26:00 -0400 DVHGD GSD O.47005133 http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Devonian+Health+Group++++++++++++++++/26820593.html <p><a target="_blank" href="http://archive.fast-edgar.com/20260727/A7BZQ22C8Z2242ZZ27ZS2CZZGWEKZ2U2ZL8G">http://archive.fast-edgar.com/20260727/A7BZQ22C8Z2242ZZ27ZS2CZZGWEKZ2U2ZL8G</a></p> <p> Filed on: July 27, 2026 </p> http://www.streetinsider.com/SEC+Filings/Form++F-1++++++++Devonian+Health+Group++++++++++++++++/26820593.html Mon, 27 Jul 2026 17:26:00 -0400 DVHGD GSD O.47005133